#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14746	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2189	667.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	850	C,T	835,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	0	.	n	.	0	T695C	SNP	695	695	T	1047	1047	C	799	C,T	781,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1689	1689	A	870	A	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2323	2323	C	807	C	792	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2397	2397	A	816	A	807	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2949	2949	C	832	C,G	813,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26636	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3555	743.9	0	HET	.	.	.	A412G	.	412	412	A	764	764	A	772	A,G	385,345	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1952	folP	855	855	100.0	folP.l15.c17.ctg.1	1630	119.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1127	1129	AGC	200;201;201	A;G;C	199;200;193	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5702	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	169.3	1	SNP	p	S91F	1	.	.	271	273	TTC	600	602	TTC	191;187;188	T;T;C	189;185;183	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5702	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	169.3	1	SNP	p	G95N	0	.	.	283	285	GGC	612	614	GGC	192;189;188	G;G;C	186;183;183	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5702	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	169.3	1	SNP	p	D95G	1	.	.	283	285	GGC	612	614	GGC	192;189;188	G;G;C	186;183;183	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1732	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1421	121.2	1	SNP	p	G45D	0	.	.	133	135	GGC	519	521	GGC	195;194;194	G,C;G,T;C	190,1;188,1;188	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	918	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1104	82.3	0	.	n	.	0	A197.	DEL	197	197	A	658	658	A	200	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.8	1	SNP	p	D86N	0	.	.	256	258	GAC	615	617	GAC	189;188;192	G,C;A;C	185,1;178;191	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.8	1	SNP	p	R87W	0	.	.	259	261	CGT	618	620	CGT	192;192;192	C,T;G;T	190,1;189;183	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.8	1	SNP	p	S87R	1	.	.	259	261	CGT	618	620	CGT	192;192;192	C,T;G;T	190,1;189;183	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.8	1	SNP	p	R87I	0	.	.	259	261	CGT	618	620	CGT	192;192;192	C,T;G;T	190,1;189;183	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4788	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.8	1	SNP	p	S88P	0	.	.	262	264	TCC	621	623	TCC	191;192;188	T;C,T;C	189;189,1;184	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4192	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2886	144.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1676	1678	GGC	195;191;190	G;G;C	188;184;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1179	1181	GCA	233;236;239	G;C;A	224;228;233	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1182	1184	ATC	239;238;236	A;T;C	235;235;230	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1194	1196	GTG	230;228;226	G;T;G	229;224;225	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1194	1196	GTG	230;228;226	G;T;G	229;224;225	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1698	1700	ACC	187;186;186	A;C;C	175;183;182	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1752	1754	GCG	153;153;154	G;C,G;G,C	141;124,2;146,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1752	1754	GCG	153;153;154	G;C,G;G,C	141;124,2;146,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1875	1877	AGC	151;147;147	A,C;G;C	146,1;142;141	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1884	1886	GGC	135;133;135	G,A;G;C	131,1;130;131	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3814	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2312	163.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1902	1904	CCG	103;105;108	C;C;G	93;94;96	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5564	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3161	175.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1690	1692	CCG	185;184;181	C;C,T;G	165;176,1;170	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2546	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1789	140.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	177	C	167	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	414	416	GAA	213;212;212	G;A;A	210;211;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	702	704	GAT	207;207;210	G;A;T	206;203;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	825	827	TCA	194;193;197	T;C;A	186;186;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	954	956	GTC	180;180;179	G;T,C;C	174;169,1;176	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	966	968	TCT	178;181;182	T;C;T	175;180;181	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1185	1187	GGT	211;211;207	G,T;G;T	204,1;203;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1284	1286	GCA	203;202;199	G;C;A	200;199;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	AAG	203;199;198	A;A;G,T	199;198;196,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	1	SNP	p	A121D	1	.	.	361	363	GAC	663	665	GAC	199;198;201	G;A;C	195;193;197	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2532	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1473	167.4	1	SNP	p	D121N	0	.	.	361	363	GAC	663	665	GAC	199;198;201	G;A;C	195;193;197	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9732	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4967	194.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1132	102.7	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	239;239;240	A;T;G,T	230;230;230,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
